Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Mallinckrodt
Moodys
Harvard Business School
Dow
US Army
McKesson
Merck
US Department of Justice

Generated: October 21, 2018

DrugPatentWatch Database Preview

Formulation information for generic ingredient: ibrutinib

« Back to Dashboard

IBRUTINIB

CASRN: 936563-96-1UNII:

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Healthtrust
US Army
Queensland Health
Julphar
McKesson
Daiichi Sankyo
Moodys
Baxter